Sector 10, Inc. (SECI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -39.84 Thousand USD | -15.23% |
| 2022 | -34.57 Thousand USD | 28.85% |
| 2021 | -48.59 Thousand USD | 94.16% |
| 2020 | -832.1 Thousand USD | -0.01% |
| 2019 | -832.02 Thousand USD | -3.93% |
| 2018 | -800.57 Thousand USD | 6.34% |
| 2017 | -854.78 Thousand USD | -3.18% |
| 2016 | -828.44 Thousand USD | -1.55% |
| 2015 | -815.83 Thousand USD | -5.78% |
| 2014 | -771.26 Thousand USD | 3.32% |
| 2013 | -797.75 Thousand USD | 0.81% |
| 2012 | -804.27 Thousand USD | 56.59% |
| 2011 | -1.85 Million USD | 57.11% |
| 2010 | -4.31 Million USD | -320.58% |
| 2009 | -1.02 Million USD | -754.93% |
| 2008 | -120.13 Thousand USD | 87.12% |
| 2007 | -932.93 Thousand USD | 22.72% |
| 2006 | -1.2 Million USD | 19.96% |
| 2005 | -1.5 Million USD | -75.01% |
| 2004 | -861.77 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -3400.00 USD | -105.07% |
| 2024 Q2 | -1658.00 USD | -223.83% |
| 2024 Q1 | -512.00 USD | 98.47% |
| 2023 Q2 | -3008.00 USD | -82.86% |
| 2023 Q3 | -1658.00 USD | 44.88% |
| 2023 Q4 | -33.53 Thousand USD | -1922.5% |
| 2023 FY | -39.84 Thousand USD | -15.23% |
| 2023 Q1 | -1645.00 USD | 78.61% |
| 2022 Q4 | -7692.00 USD | -6.77% |
| 2022 Q1 | -11.18 Thousand USD | -1804.88% |
| 2022 Q2 | -8498.00 USD | 24.02% |
| 2022 FY | -34.57 Thousand USD | 28.85% |
| 2022 Q3 | -7204.00 USD | 15.23% |
| 2021 FY | -48.59 Thousand USD | 94.16% |
| 2021 Q1 | -209.62 Thousand USD | 9.21% |
| 2021 Q2 | -171.95 Thousand USD | 17.97% |
| 2021 Q3 | -11.57 Thousand USD | 93.27% |
| 2021 Q4 | 656.00 USD | 105.67% |
| 2020 Q1 | -207.91 Thousand USD | 0.33% |
| 2020 Q4 | -230.89 Thousand USD | -16.37% |
| 2020 Q3 | -198.42 Thousand USD | -1.82% |
| 2020 FY | -832.1 Thousand USD | -0.01% |
| 2020 Q2 | -194.87 Thousand USD | 6.27% |
| 2019 Q1 | -205.98 Thousand USD | -0.13% |
| 2019 FY | -832.02 Thousand USD | -3.93% |
| 2019 Q4 | -208.61 Thousand USD | -0.29% |
| 2019 Q3 | -208 Thousand USD | 0.67% |
| 2019 Q2 | -209.41 Thousand USD | -1.67% |
| 2018 Q1 | -197.82 Thousand USD | 4.84% |
| 2018 FY | -800.57 Thousand USD | 6.34% |
| 2018 Q4 | -205.72 Thousand USD | -3.99% |
| 2018 Q3 | -197.82 Thousand USD | 0.7% |
| 2018 Q2 | -199.21 Thousand USD | -0.71% |
| 2017 Q1 | -188.5 Thousand USD | 9.69% |
| 2017 FY | -854.78 Thousand USD | -3.18% |
| 2017 Q4 | -207.89 Thousand USD | 13.38% |
| 2017 Q3 | -240 Thousand USD | -9.89% |
| 2017 Q2 | -218.39 Thousand USD | -15.86% |
| 2016 FY | -828.44 Thousand USD | -1.55% |
| 2016 Q3 | -205.54 Thousand USD | 1.37% |
| 2016 Q2 | -208.39 Thousand USD | -1.28% |
| 2016 Q4 | -208.73 Thousand USD | -1.55% |
| 2016 Q1 | -205.76 Thousand USD | 1.84% |
| 2015 Q4 | -209.62 Thousand USD | -11.45% |
| 2015 Q2 | -210.01 Thousand USD | -0.92% |
| 2015 FY | -815.83 Thousand USD | -5.78% |
| 2015 Q1 | -208.09 Thousand USD | -3.85% |
| 2015 Q3 | -188.09 Thousand USD | 10.44% |
| 2014 Q1 | -193.46 Thousand USD | 7.64% |
| 2014 FY | -771.26 Thousand USD | 3.32% |
| 2014 Q2 | -182.36 Thousand USD | 5.74% |
| 2014 Q3 | -195.05 Thousand USD | -6.96% |
| 2014 Q4 | -200.38 Thousand USD | -2.73% |
| 2013 FY | -797.75 Thousand USD | 0.81% |
| 2013 Q4 | -209.45 Thousand USD | 7.85% |
| 2013 Q3 | -227.28 Thousand USD | -7.92% |
| 2013 Q2 | -210.61 Thousand USD | -40.04% |
| 2013 Q1 | -150.39 Thousand USD | 50.54% |
| 2012 Q1 | -212.5 Thousand USD | 90.67% |
| 2012 FY | -804.27 Thousand USD | 56.59% |
| 2012 Q4 | -304.1 Thousand USD | -121.35% |
| 2012 Q3 | -137.38 Thousand USD | 8.58% |
| 2012 Q2 | -150.28 Thousand USD | 29.28% |
| 2011 FY | -1.85 Million USD | 57.11% |
| 2011 Q4 | -2.27 Million USD | -3975.61% |
| 2011 Q3 | -55.91 Thousand USD | 89.1% |
| 2011 Q2 | -513.09 Thousand USD | -77.28% |
| 2011 Q1 | -289.42 Thousand USD | 90.9% |
| 2010 Q4 | -3.17 Million USD | -665.41% |
| 2010 FY | -4.31 Million USD | -320.58% |
| 2010 Q1 | -412.33 Thousand USD | 23.53% |
| 2010 Q2 | -312.2 Thousand USD | 24.28% |
| 2010 Q3 | -415.39 Thousand USD | -33.05% |
| 2009 Q2 | -130.62 Thousand USD | 45.6% |
| 2009 Q3 | -117.03 Thousand USD | 10.41% |
| 2009 FY | -1.02 Million USD | -754.93% |
| 2009 Q4 | -539.24 Thousand USD | -360.76% |
| 2009 Q1 | -240.13 Thousand USD | -291.82% |
| 2008 Q1 | -325.62 Thousand USD | -120.16% |
| 2008 FY | -120.13 Thousand USD | 87.12% |
| 2008 Q4 | -61.28 Thousand USD | -4.15% |
| 2008 Q3 | -58.84 Thousand USD | 81.93% |
| 2008 Q2 | -325.62 Thousand USD | 0.0% |
| 2007 Q2 | -615.81 Thousand USD | -51.77% |
| 2007 Q4 | 1.61 Million USD | 205.88% |
| 2007 FY | -932.93 Thousand USD | 22.72% |
| 2007 Q1 | -405.76 Thousand USD | -110.33% |
| 2007 Q3 | -1.52 Million USD | -147.73% |
| 2006 FY | -1.2 Million USD | 19.96% |
| 2006 Q4 | -192.91 Thousand USD | 24.78% |
| 2006 Q3 | -256.47 Thousand USD | 17.67% |
| 2006 Q2 | -311.53 Thousand USD | -84.35% |
| 2006 Q1 | -168.98 Thousand USD | 52.46% |
| 2005 Q2 | -433.14 Thousand USD | -30.58% |
| 2005 FY | -1.5 Million USD | -75.01% |
| 2005 Q1 | -331.72 Thousand USD | 61.41% |
| 2005 Q4 | -355.44 Thousand USD | 8.47% |
| 2005 Q3 | -388.32 Thousand USD | 10.35% |
| 2004 FY | -861.77 Thousand USD | 0.0% |
| 2004 Q4 | -859.5 Thousand USD | -15978.46% |
| 2004 Q2 | -257.26 Thousand USD | -11208.31% |
| 2004 Q3 | 5413.00 USD | 102.1% |
| 2004 Q1 | -2275.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 103.422% |
| Ansell Limited | 129.3 Million USD | 100.031% |
| Ansell Limited | 129.3 Million USD | 100.031% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 100.128% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 97.503% |
| Psykey, Inc. | -797.5 Thousand USD | 95.004% |
| ConvaTec Group Plc | 262.7 Million USD | 100.015% |
| ConvaTec Group Plc | 262.7 Million USD | 100.015% |
| Encision Inc. | -640.78 Thousand USD | 93.782% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 71.903% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 63.755% |
| Innovative MedTech Inc. | -4.27 Million USD | 99.068% |
| LifePoint, Inc. | -7.49 Million USD | 99.468% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 99.385% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 112.074% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 67.578% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 91.473% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.983% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.012% |
| SheerVision, Inc. | 155.72 Thousand USD | 125.586% |
| United Health Products, Inc. | -2.42 Million USD | 98.358% |
| Vasamed, Inc. | 4.74 Million USD | 100.84% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 98.263% |
| Yubo International Biotech Limited | -1.2 Million USD | 96.694% |